Marc Wilson is CFO at Crinetics Pharmaceuticals, Inc. (CRNX). They have made 1 open-market trade across 1 company since 2023, most recently 2024-09-26.
CIK 0001702265
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRNX | SELL · 10b5-1 | 2024-09-26 | 2024-09-30 | $51.11 | $1.3M | +2.1% | +10.0% | -0.1% |
| CRNX | SELL · 10b5-1 | 2024-07-25 | 2024-07-26 | $53.88 | $2.1M | -11.3% | -2.4% | +7.9% |
| CRNX | SELL · 10b5-1 | 2024-07-15 | 2024-07-17 | $55.00 | $1.4M | +1.4% | -3.6% | +7.6% |
| CRNX | SELL · 10b5-1 | 2024-06-28 | 2024-07-02 | $43.61 | $2.8M | +19.1% | +14.5% | +12.4% |
| CRNX | SELL · 10b5-1 | 2024-03-19 | 2024-03-20 | $42.91 | $596K | +0.3% | -6.3% | -3.4% |
| CRNX | SELL · 10b5-1 | 2024-01-02 | 2024-01-04 | $35.47 | $355K | +7.8% | +10.3% | +39.5% |
| CRNX | SELL · 10b5-1 | 2023-11-01 | 2023-11-03 | $28.75 | $288K | -5.8% | +8.9% | +21.3% |
| CRNX | SELL | 2023-06-20 | 2023-06-21 | $19.96 | $835K | -8.1% | -4.6% | +49.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.